Impact Report | HonorHealth Research Institute
Elevating research
Your kindness, compassion and generosity are shaping the future of medicine by empowering HonorHealth Research Institute with the resources to pioneer groundbreaking treatments, advance innovative technologies and expand scientific knowledge — bringing hope and healing to patients and their loving families in our community and across the globe.
Through our clinical trials and applied research, we’ve given hope and improved the lives of patients from all 50 states and 30 different countries. It’s the generosity of donors that has made the Institute a destination for treatments, often available nowhere else in the world.
Philanthropy makes this and so much more possible. YOU are the driving force behind life-changing advancements, ensuring that groundbreaking discoveries reach those who need them most.
With your continued support, our dedicated physicians and scientists will push the boundaries of medicine, uncover innovative new strategies and offer renewed hope to patients who often have exhausted all other options.
And for that, we thank you!
Your impact
Download the HonorHealth Research Institute Impact Report(PDF format)
“We have attracted among the world’s best researchers, physicians and other healthcare workers. They could choose to go anywhere in the world, but they choose to be here — because we are elevating research.”
— MARK A. SLATER, PhD
CEO, HonorHealth Research Institute
Making great care possible is just the beginning!
Through the generosity of compassionate donors like you, HonorHealth Research Institute’s renowned team of experts provides new hope to patients with rare, recurring or difficult-to-treat conditions.
Because of your kindness, the Institute has reached new heights by elevating research on every level across a growing list of medical disciplines. Through new treatments, new devices and new technologies, all designed to make a substantial difference in the lives of patients, they are poised for an explosion of scientific discovery!
Among many significant achievements in 2024 was October’s announcement of a partnership between HonorHealth and Arizona State University, in which HonorHealth will serve as the primary clinical affiliate for ASU’s new School of Medicine and Advanced Medical Engineering.
One of the reasons HonorHealth was selected by ASU for this venture is because of the great work that has been accomplished in research over the past two decades at the Institute.
HonorHealth Research Institute is known for its innovation; for the ability to do things first, not only in the development of innovative new drugs, but in creating innovative devices, techniques and standards of care.
These innovations are made possible by the visionary philanthropy of donors. You deliver an immediate impact, providing new answers to our patients and their families, many of whom had lost hope.
Accomplishing the incredible!
In 2023, HonorHealth Research Institute delivered transformative advancements in research and innovation, enhancing patient care.
By integrating the latest scientific discoveries with clinical excellence, the Institute achieved remarkable successes, driving better outcomes while elevating the standard of care, including:
-
- 241 active clinical studies
- 139 active investigators
- 53 new clinical studies initiated
- 4 FDA novel therapy approvals
- 210 research publications
- 3,003 clinic patient visits
Because of you
As a nonprofit, community-based healthcare system, HonorHealth relies on your kindness and generosity to help provide the exceptional care you and your family expect and deserve.
Every patient’s experience with HonorHealth is enhanced through philanthropy. Because of you, HonorHealth Research Institute is unraveling not only the secrets of cancer, but also of the neurosciences, cardiology and other medical disciplines. Your generous gift ensures the expansion of vital research and services for you, the people you love…and countless others.
Giving through HonorHealth Foundation means you’re supporting more than great care — your contributions improve health and well-being, fuel medical breakthroughs, drive innovative research and so much more.
Your generosity in action
Roslyn “Sunny” Gomes of Glendale, Arizona was one of the first patients in the nation — and the first in Arizona — to undergo a non-surgical, catheter-based procedure with a new type of stroke-prevention stent that eliminates blockages in neck arteries that could potentially cause a deadly stroke by depriving the brain of oxygen.
Sunny, 76, has suffered from peripheral artery disease for years. She already has three stents in her heart and so many stents and replacement arteries in both her legs that she’s lost count.
A previous scan some years ago revealed a partial blockage of her right carotid artery, but a recent set of scans showed it was 85 percent blocked, making her a good candidate for the new clinical trial.
The Neuroguard Integrated Embolic Protection (IEP) system is an experimental treatment for carotid artery stenosis, also known as carotid artery disease. This is a condition in which fattywaxy deposits build up and block the normal flow of blood in the large arteries on either side of the neck. Left untreated, this condition can lead to stroke with severe complications, including death.
“I feel a lot better today than I have,” said Sunny, days after her procedure. “I really love all of my doctors. They’ve been really good to me. They’ve saved my right leg twice now.”
Download the HonorHealth Research Institute Impact Report (PDF format)
Support
Thank you for your continued support of HonorHealth Research Institute!